The cost of Wegovy will soon be covered by Medicare, according to an announcement from the federal health insurance program for seniors on
CR/Getty Images
Veterinary scientists seem to have unraveled a mystery about why certain dogs simply can’t ever get enough to eat. In research out this week, they found evidence that a common mutation in Labrador retrievers causes them to experience greater hunger than usual while also reducing their metabolic rate, both of which…
A lifetime of snacking and frozen food dinners may affect your body in lots of surprising ways, new research suggests. The study, a large-scale review of the existing evidence, found an association between regularly eating ultra-processed foods and a higher risk of many health problems. It also found that these foods…
The newest obesity drug on the market, Eli Lilly’s tirzepatide, may also help keep people’s blood pressure in check, new research out Monday has shown. The study looked at clinical trial participants and found that people taking it experienced a drop in their systolic blood pressure on average compared to a placebo…
A popular class of weight loss drugs may offer more lasting success than assumed, new data from Epic Research suggests. The study of medical records found that a slight majority of people who took GLP-1 drugs like semaglutide either maintained or improved their weight loss in the year after they stopped using the…
PSG
Few prescription drugs have entered the public consciousness as abruptly as Ozempic and Wegovy have in recent years. Novo Nordisk’s brand-name medications have become as synonymous with weight loss as Viagra and Cialis are with erectile dysfunction. But while 2023 has made it clear that these and similar drugs really…
New research shows that tirzepatide, the latest FDA-approved obesity drug, really can help people lose substantial amounts of weight—but only if they continue taking it. The study found that people who stopped taking tirzepatide after 36 weeks regained much of their lost weight within a year, while those who continued…
A study out this week suggests that semaglutide—the active ingredient in popular obesity drug Wegovy—might be able to help people struggling with alcohol use disorder, too. In a small sample of cases, researchers found evidence that people who took semaglutide for weight loss also experienced a significant reduction…